Related references
Note: Only part of the references are listed.Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
Oliver E. Amin et al.
HEPATOLOGY (2021)
Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis
Qian Li et al.
CELL DEATH & DISEASE (2021)
Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model
Yanqin Du et al.
ACTA BIOMATERIALIA (2021)
Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway via Interaction With the TAK1-TAB2 Complex
Feiyan Deng et al.
FRONTIERS IN IMMUNOLOGY (2021)
In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application
Yanqin Du et al.
FRONTIERS IN IMMUNOLOGY (2021)
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming
Giorgia De Simone et al.
IMMUNITY (2021)
Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus Infection
Sahar Asadi-Asadabad et al.
VIRAL IMMUNOLOGY (2021)
Follicular Helper T (T-FH) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients
Natarajan Ayithan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients
Yingying Dou et al.
ANTIVIRAL RESEARCH (2020)
Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes
Zhenhua Zhang et al.
HEPATOLOGY (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B
Richard L. Mackman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+T cells
Hu Yan et al.
IMMUNOLOGY (2020)
Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus Infection
Atsushi Yonejima et al.
HEPATOLOGY (2019)
Toll-Like Receptor 7 Activation Enhances CD8+T Cell Effector Functions by Promoting Cellular Glycolysis
Qian Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
TLR2 Stimulation Increases Cellular Metabolism in CD8+ T Cells and Thereby Enhances CD8+ T Cell Activation, Function, and Antiviral Activity
Ejuan Zhang et al.
JOURNAL OF IMMUNOLOGY (2019)
TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection
I Sghaier et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2019)
HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo
Yingying Dou et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naive patients: a case-control study in a Han Chinese population
Yong Lin et al.
BMC INFECTIOUS DISEASES (2018)
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
Aleksei Suslov et al.
GASTROENTEROLOGY (2018)
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2018)
Immunotherapy for Chronic Hepatitis B Virus Infection
Antonio Bertoletti et al.
GUT AND LIVER (2018)
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
Harry L. A. Janssen et al.
JOURNAL OF HEPATOLOGY (2018)
Local Stimulation of Liver Sinusoidal Endothelial Cells with a NOD1 Agonist Activates T Cells and Suppresses Hepatitis B Virus Replication in Mice
Shunmei Huang et al.
JOURNAL OF IMMUNOLOGY (2018)
TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production
Jia Liu et al.
JOURNAL OF IMMUNOLOGY (2018)
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment
K. Agarwal et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
Julie Lucifora et al.
SCIENTIFIC REPORTS (2018)
Pre-Activation of Toll-Like Receptor 2 Enhances CD8+ T-Cell Responses and Accelerates Hepatitis B Virus Clearance in the Mouse Models
Yong Lin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
Yvan Hutin et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection
Loghman Salimzadeh et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8(+) T Cell Responses
Yasuhiro Murata et al.
JOURNAL OF VIROLOGY (2018)
Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection
Forough Golsaz-Shirazi et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population
Janett Fischer et al.
SCIENTIFIC REPORTS (2018)
Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B
Zhiyong Ma et al.
VACCINES (2018)
Kupffer cells in immune activation and tolerance toward HBV/HCV infection
Fangchao Yuan et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy
Guangying Deng et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients
K. Visvanathan et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection
Sukriti Sukriti et al.
HEPATOLOGY INTERNATIONAL (2016)
Adaptive immunity in HBV infection
Antonio Bertoletti et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism
Nadine van Montfoort et al.
JOURNAL OF VIROLOGY (2016)
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J. Gane et al.
JOURNAL OF HEPATOLOGY (2015)
Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice
Mm Li et al.
JOURNAL OF IMMUNOLOGY (2015)
Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses
Zhiyong Ma et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
The role of hepatic immune regulation in systemic immunity to viral infection
Percy A. Knolle et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection
Ejuan Zhang et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
IL-6 Plays a Crucial Role in HBV Infection
Tian Lan et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients
Mohammad Momeni et al.
HUMAN IMMUNOLOGY (2014)
Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen
M. Jiang et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Poly(I:C) Treatment Leads to Interferon-Dependent Clearance of Hepatitis B Virus in a Hydrodynamic Injection Mouse Model
Jun Wu et al.
JOURNAL OF VIROLOGY (2014)
Hepatitis B Virus Polymerase Suppresses NF-κB Signaling by Inhibiting the Activity of IKKs via Interaction with Hsp90β
Dan Liu et al.
PLOS ONE (2014)
Toll-Like Receptor 8 Agonist and Bacteria Trigger Potent Activation of Innate Immune Cells in Human Liver
Juandy Jo et al.
PLOS PATHOGENS (2014)
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
Yi-Wen Huang et al.
ANTIVIRAL THERAPY (2013)
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion
Dimitra Peppa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
TLR1/2 Ligand-Stimulated Mouse Liver Endothelial Cells Secrete IL-12 and Trigger CD8+ T Cell Immunity In Vitro
Jia Liu et al.
JOURNAL OF IMMUNOLOGY (2013)
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+T cells and successful immunotherapy against chronic viral liver infection
Li-Rung Huang et al.
NATURE IMMUNOLOGY (2013)
Liver-Primed Memory T Cells Generated under Noninflammatory Conditions Provide Anti-infectious Immunity
Jan P. Boettcher et al.
CELL REPORTS (2013)
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
Anna Schurich et al.
PLOS PATHOGENS (2013)
Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B
Ning Xu et al.
INFLAMMATION RESEARCH (2012)
Pattern recognition receptor responses in children with chronic hepatitis B virus infection
Ida Louise Heiberg et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Mechanisms Balancing Tolerance and Immunity in the Liver
Jan P. Boettcher et al.
DIGESTIVE DISEASES (2011)
Cross-Presentation of Antigen by Diverse Subsets of Murine Liver Cells
Mohammad R. Ebrahimkhani et al.
HEPATOLOGY (2011)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway
Tali Lang et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function
Andrea M. Woltman et al.
PLOS ONE (2011)
Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells
Isabelle E. Vincent et al.
PLOS ONE (2011)
When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function
Degui Geng et al.
BLOOD (2010)
Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific
Jun Wu et al.
IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
The divergence and interplay between pDC and mDC in humans
Norimitsu Kadowaki
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection
Claire Dunn et al.
GASTROENTEROLOGY (2009)
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection
P. Fisicaro et al.
GUT (2009)
Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells
Jun Wu et al.
HEPATOLOGY (2009)
Not Interferon, but Interleukin-6 Controls Early Gene Expression in Hepatitis B Virus Infection
Marianna Hoesel et al.
HEPATOLOGY (2009)
HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells
Yongfen Xu et al.
MOLECULAR IMMUNOLOGY (2009)
Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9
Qing Xie et al.
MICROBES AND INFECTION (2009)
Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma
Ning Xu et al.
ACTA PHARMACOLOGICA SINICA (2008)
Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients
Zhiao Chen et al.
CLINICAL IMMUNOLOGY (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
Qiang You et al.
HEPATOLOGY (2008)
Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection
S. Tavakoli et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
Jun Wu et al.
HEPATOLOGY (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor
Julie Tabiasco et al.
JOURNAL OF IMMUNOLOGY (2006)
TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation
Anne Cottalorda et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
M Isogawa et al.
JOURNAL OF VIROLOGY (2005)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
TLR2 is expressed on activated T cells as a costimulatory receptor
M Komai-Koma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B
RG van der Molen et al.
HEPATOLOGY (2004)
Selective functional deficit in dendritic cell - T cell interaction is a crucial mechanism in chronic hepatitis B virus infection
BJ Zheng et al.
JOURNAL OF VIRAL HEPATITIS (2004)
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection
R Thimme et al.
JOURNAL OF VIROLOGY (2003)
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice
K Kimura et al.
JOURNAL OF VIROLOGY (2002)
Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes
P Vanlandschoot et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Kupffer cell-mediated recruitment of rat dendritic cells to the liver:: Roles of N-acetylgalactosamine-specific sugar receptors
R Uwatoku et al.
GASTROENTEROLOGY (2001)